| 发明名称 |
TREATMENT OF MYELODYSPLASTIC SYNDROME |
| 摘要 |
The present invention relates to the use of Volasertib or a pharmaceutically acceptable salt thereof or the hydrate thereof for treating myelodysplastic syndrome (MDS). |
| 申请公布号 |
US2015031699(A1) |
申请公布日期 |
2015.01.29 |
| 申请号 |
US201414340037 |
申请日期 |
2014.07.24 |
| 申请人 |
RUDOLPH Dorothea;TAUBE Tillmann |
发明人 |
RUDOLPH Dorothea;TAUBE Tillmann |
| 分类号 |
A61K31/519 |
主分类号 |
A61K31/519 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of treating MDS comprising administering to a patient a therapeutically effective amount of Volasertib, optionally in the form of a pharmaceutically acceptable salt thereof or a hydrate thereof. |
| 地址 |
Vienna AT |
